The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Anyone who has been watching medical opinions on Covid will appreciate that this dreadful virus isn't going to vanish. The limitations of vaccines is all to obvious, indeed some medics argue that it was the wrong approach to mass vaccinate because this causes mutations to appear all the faster. I don't know about that, only time will tell.
However, it does mean that products which can alleviate symptoms for sufferers will have a long term future The list of ailments which can be positively affected by Fruitflow has grown and grown.
All the more puzzling is the zombie market for shares right now.
At this rate of "progress", it's likely a lot of the lifers on here will be passing the baton and the poisoned chalice to their descendants!
It's a pretty grim situation really isn't it?
Today's is even stranger.
Why would there be so many PMA's lately on such miniscule trades?
Thanks, gixer :)
https://www.tmsearch.cn/trademark-owner-search-china/provexis
Translates to lerosol or something similar.
Not heard from David for a while. It would be good to have his thoughts on a few things.
Couldn't say what the correct translation is but this is By-Healths trade mark for it
https://www.tmsearch.cn/trademark-name-search-china/%E6%96%B0%E7%BB%9C%E7%B4%A0
Very similar to the Chinese trademark for Fruitflow that Provexis holds. 2 of the 3 characters are the same.
Thank you for the links :)
Is David from China about on this forum, as I'm keen to know exactly what Xinluosu means.
Does it literally mean natural Aspirin?
Thank you
Yes your right. Was close LOL
P.S. I think you mean Krijn Rietveld.
kievsky, I will see after the results are posted and what questions remain unanswered.
I would assume our man at DSM will be there, if Covid restrictions allow.
Gix, think we should meet before the AGM starts and have a list of questions for them (that's of course you can make it). I will ask IF if a member of DSM can be there this year. Seen no one since the late Rudi died
wellsite, I feel a little frustration in your comment :)
Thing is, every positive study is a bonus to Provexis no matter who carries it out.
As for IF. Not sure who you think would be able to replace him and 2p might be a bit enthusiast unless blue cap comes before the year end.
W$. Yes I am hoping for 3p +. Of course if blue cap is given by then. I am sure IF is well aware of the frustration share holders are feeling including SL. As long as he holds and my bet still buying on the dips then we should be fine
Gix
more studies blah blah bloody blah.
If the SP isn't past 2 p by the end of the year IF has to go.........over to you Ian
W$
Looking for recruitments
" The main raw material of Xinluoxu tablets is naturally extracted water-soluble tomato concentrate, which is known as "natural aspirin". European scientific research institutions lasted for 10 years and after a number of clinical trials, it was confirmed that "Xinluoxin" can help the human body to maintain normal Platelet function contributes to healthy blood flow without side effects. The health product has been launched in Europe and won the "Best Heart Care Innovation Award" at the European Health Food Ingredients Exhibition."
https://weibo.com/2128410557/Ku8vbrSJp?from=page_1001062128410557_profile&wvr=6&mod=weibotime&type=comment
https://mp.weixin.qq.com/s/-12oXc9XRfSHFUlmuqx-Xw
Hi W$. Once (hope) bi-health get bluecap they will spend a lot of money promoting fruitflow and what it can do. Yes AGM should be very interesting.
The prof's presentations & expected medical paper show things are going on. I don't think IF is sitting back, he has to deliver to the investors who stumped up £1 mill smackeroos.
It is just very frustrating that we have a product that could help so many people if they only knew about it. I put pollution in the same bucket as long covid re potential scale of demand and customer demographic. I would like to see a FF tablet with nothing else added, like the gixer found for Iran. Would be cheaper and appeal to more.
That said, we need the supply chain in place to deliver the potential demand. The £1m goes only so far
Looking forward to the AGM, I'm sure IF has some good updates to share
W$
Hi wellsite,
Good post. Hope 0ur sleeping IF is following all these wonderful research to help those people and sell fruitflow. It is a lifetime opportunity and he must capture it not just by taking his salary and have a very comfortable life.
https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/coronavirus-and-your-health/long-covid/what-do-we-know-about-long-covid?utm_campaign=1895628_HeartMatters_enewsletter_NonHCP_Aug2021_2&utm_medium=email&utm_source=British%20Heart%20Foundation%20%28BHF%29%20&mi_u=8-18884270#Heading11
Do blood clots cause long Covid symptoms?
New evidence from blood tests of people with long Covid suggests that symptoms such as reduced fitness and fatigue may be caused by blood clots. Researchers studied 50 people with long Covid symptoms and found that, compared to healthy people in a ‘control group’, they had higher levels of substances involved in blood clotting. The people who had needed treatment in hospital for their initial Covid illness had higher levels of these substances (known as markers). But people who’d had less severe Covid still had them at higher levels than the healthy control group.
Some research has suggested that long Covid could be caused by inflammation (which results from your immune system reacting to a threat, such as a virus), but in this study, signs of clotting remained at high levels in the blood after substances related to inflammation had returned to normal levels. Clotting is part of your body’s normal response to injury, in order to stop bleeding, but when it happens too much, it can have harmful effects.
The study also found evidence that in people with long Covid, the cells that line the walls of blood vessels were releasing substances that are involved in blood clotting. The researchers said these findings suggested that blood clots, for example in the lungs, could be causing the long Covid symptoms people in the study were experiencing.
The study’s lead author, Dr Helen Fogarty, said: “Because clotting markers were elevated while inflammation markers had returned to normal, our results suggest that the clotting system may be involved in the root cause of long Covid syndrome.”
“Understanding the root cause of a disease is the first step toward developing effective treatments,” said Professor James O’Donnell, Director of the Irish Centre for Vascular Biology, RCSI (an international university in Dublin), which helped fund the research.
It's important to understand that this is a small study, and more research is needed to confirm these results.
Bed & ISA for 24.15K? How?
No. I think that is bed&ISA. So someone is transferring from normal investment account to ISA.
Yes that's what I said. But for every seller is a buyer. Someone's accumulating
That 3 million must be a sell
I can see what you mean. It's been painful and taken a long time. Especially the SIS episode.
I had to average down from 6/8 pence, and still down on my investment, but this thing could absolutely fly in China's 1.4 billion population.
So much potential in China with Blue Hat status and fits into the Healthy China 2030 plan.
Extremely well scientifically substantiated product too.